Recombinant c1 esterase inhibitor for short-term prophylaxis in patients with hereditary angioedema

This study evaluated recombinant C1 esterase inhibitor (rhC1-INH) as short-term prophylaxis.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: A. Zanichelli, M. Staevska, M. Jesenak, K. Hrubiskova, M. Sobotkova, R. Zachova, R. Hakl, S. Andrejevic, T. Suiter, V. Grivcheva-Panovska, L. Karadza-Lapic, D. Soteres, R. Shapiro, J. Rumbyrt, R. Tachdjian, V. Mehta, F. Hsu, A. Valerieva Tags: P167 Source Type: research